Shibin Zhou

40.8k citations

66 papers · 14.9k indexed · 7 hit papers · h-index 38

Cancer Research top 0.2%
Biotechnology top 0.1%
- Cancer Research and Treatments 19
Oncology top 0.5%
- CAR-T cell therapy research 10
Molecular Biology top 0.5%
- TGF-β signaling in diseases 6
Immunology top 1%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 11
Genetics
- Virus-based gene therapy research 10
Biomedical Engineering
- Nanoplatforms for cancer theranostics 9
Ecology
- Bacteriophages and microbial interactions 7
Materials Chemistry
- Lanthanide and Transition Metal Complexes 6

Co-authors: Bert Vogelstein Kenneth W. Kinzler Luis A. Díaz Nickolas Papadopoulos Victor E. Velculescu Jian Yu Tong‐Chuan He Luís Teixeira da Costa
Cited by: Cancer Research Biotechnology Oncology
Journals: Nature (1 paper)Science (3 papers)Proceedings of the National Academy of Sciences (13 papers)
Partner nations: United States China Hong Kong

In The Last Decade

Shibin Zhou

63 papers receiving 14.7k citations

Hit Papers

7 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2024 Nature reviews. Cancer
2018 Nature reviews. Cancer
2014 Proceedings of the National Academy of Sciences
2013 Science
2009 Science
1998 Molecular Cell
1998 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Shibin Zhou

Since Specialization

Citations

This map shows the geographic impact of Shibin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shibin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shibin Zhou more than expected).

Fields of papers citing papers by Shibin Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shibin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shibin Zhou. The network helps show where Shibin Zhou may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shibin Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shibin Zhou Line = papers co-authored together Shibin Zhou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The role of ion channels in the regulation of dendritic cell function Cell Calcium ·Shibin Zhou,Lanlan Zhong,Yilan Wu,Sungchul Ji,Yong Li,Na Niu	2025	2
2	NXPE1 alters the sialoglycome by acetylating sialic acids in the human colon Nature Communications ·Bum Seok Lee,Ashley L. Cook,Surojit Sur,Laura Dobbyn,Maria Popoli,Sana Khalili,Shibin Zhou,Chetan Bettegowda,Nickolas Papadopoulos,Kathleen L. Gabrielson,Phillip Buckhaults,Bert Vogelstein,Kenneth W. Kinzler,Nicolas Wyhs	2025	1
3	Epithelial sodium channel in dendritic cells participates in high-fat-induced inflammatory responses Molecular Biology Reports ·Li Xu,Shibin Zhou,Lin Bai,Chunlei Yu,Na Niu	2025	0
4	Setting “cold” tumors on fire: Cancer therapy with live tumor-targeting bacteria Med ·Simin Manole,Dinh-Huy Nguyen,Jung-Joon Min,Shibin Zhou,(unknown)	2024	5
5	ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1 eLife ·Jordina Rincón-Torroella,Marco Dal Molin,Brian J. Mog,Gyuri Han,Evangeline Watson,Nicolas Wyhs,Shun Ishiyama,Taha Ahmedna,Il Minn,Nilofer S. Azad,Chetan Bettegowda,Nickolas Papadopoulos,Kenneth W. Kinzler,Shibin Zhou,Bert Vogelstein,Kathleen L. Gabrielson,Surojit Sur	2024	0
6	An isogenic cell line panel for sequence-based screening of targeted anticancer drugs iScience ·Ashley L. Cook,Nicolas Wyhs,Surojit Sur,Blair Ptak,Maria Popoli,Laura Dobbyn,Tasos Papadopoulos,Chetan Bettegowda,Nickolas Papadopoulos,Bert Vogelstein,Shibin Zhou,Kenneth W. Kinzler	2022	4
7	Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists Journal of Clinical Investigation ·Maximilian F. Konig,Michael Powell,Verena Staedtke,Ren-Yuan Bai,David L. Thomas,Nicole Fischer,Sakibul Huq,Adham M. Khalafallah,Allison Koenecke,Ruoxuan Xiong,Brett D. Mensh,Nickolas Papadopoulos,Kenneth W. Kinzler,Bert Vogelstein,Joshua T Vogelstein,Susan Athey,Shibin Zhou,Chetan Bettegowda	2020	87
8	An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation Journal of Biological Chemistry ·Michelle S. Miller,Jacqueline Douglass,Michael S. Hwang,Andrew D. Skora,Michael Murphy,Nickolas Papadopoulos,Kenneth W. Kinzler,Bert Vogelstein,Shibin Zhou,Sandra B. Gabelli	2019	14
9	Tumour-targeting bacteria engineered to fight cancerbreakdown → Nature reviews. Cancer ·Shibin Zhou,Claudia Gravekamp,David Bermudes,Ke Liu	2018	608
10	Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome Nature ·Verena Staedtke,Ren-Yuan Bai,Kibem Kim,Martin Darvas,Marco L. Davila,Gregory J. Riggins,Paul B. Rothman,Nickolas Papadopoulos,Kenneth W. Kinzler,Bert Vogelstein,Shibin Zhou	2018	191
11	Characterization of tumor vascular permeability using natural dextrans and CEST MRI Magnetic Resonance in Medicine ·Yuguo Li,Yuan Qiao,Hanwei Chen,Ren-Yuan Bai,Verena Staedtke,Zheng Han,Jiadi Xu,Kannie W. Y. Chan,Nirbhay N. Yadav,Jeff W. M. Bulte,Shibin Zhou,Peter C.M. van Zijl,Guanshu Liu	2017	35
12	A diaCEST MRI approach for monitoring liposomal accumulation in tumors Journal of Controlled Release ·Kannie W. Y. Chan,Tao Yu,Yuan Qiao,Qiang Liu,Ming Yang,Himatkumar V. Patel,Guanshu Liu,Kenneth W. Kinzler,Bert Vogelstein,Jeff W. M. Bulte,Peter C.M. van Zijl,Justin Hanes,Shibin Zhou,Michael T. McMahon	2014	50
13	Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma Nature Genetics ·Meng Li,Hong Zhao,(unknown),Laura D. Wood,Robert A. Anders,Michael A. Choti,Timothy M. Pawlik,Hubert Darius J. Daniel,Rajesh Kannangai,G. Johan A. Offerhaus,Victor E. Velculescu,Linfang Wang,Shibin Zhou,Bert Vogelstein,Ralph H. Hruban,Nikolaos G. Papadopoulos,Jianqiang Cai,Michael Torbenson,Kenneth W. Kinzler	2011	302
14	Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cellsbreakdown → Science ·Jihye Yun,Carlo Rago,Ian Cheong,Ray Pagliarini,Philipp Angenendt,Harith Rajagopalan,Kerstin Schmidt,James K. V. Willson,Sandy D. Markowitz,Shibin Zhou,Luis A. Díaz,Victor E. Velculescu,Christoph Lengauer,Kenneth W. Kinzler,Bert Vogelstein,Nickolas Papadopoulos	2009	724
15	Chapter 13 Tumor-Specific Liposomal Drug Release Mediated by Liposomase Methods in enzymology on CD-ROM/Methods in enzymology ·Ian Cheong,Shibin Zhou	2009	13
16	A Bacterial Protein Enhances the Release and Efficacy of Liposomal Cancer Drugs Science ·Ian Cheong,Xin Huang,Chetan Bettegowda,Luis A. Díaz,Kenneth W. Kinzler,Shibin Zhou,Bert Vogelstein	2006	136
17	The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT Nature Biotechnology ·Chetan Bettegowda,Xin Huang,Jimmy Lin,Ian Cheong,Manu Kohli,Stephen A Szabo,Xiaosong Zhang,Luis A. Díaz,Victor E. Velculescu,Giovanni Parmigiani,Kenneth W. Kinzler,Bert Vogelstein,Shibin Zhou	2006	126
18	DEC1 is a downstream target of TGF-β with sequence-specific transcriptional repressor activities Proceedings of the National Academy of Sciences ·Leigh Zawel,Jian Yu,C Torrance,Sanford D. Markowitz,Kenneth W. Kinzler,Bert Vogelstein,Shibin Zhou	2002	81
19	Characterization of Human FAST-1, a TGFβ and Activin Signal Transducer Molecular Cell ·Shibin Zhou,Leigh Zawel,Christoph Lengauer,K. W. Kinzler,Bert Vogelstein	1998	208
20	Characterization of a novel synapse-specific protein. I. Developmental expression and cellular localization of the F1-20 protein and mRNA Journal of Neuroscience ·Rui Sousa,Nancy Hrinya Tannery,Shibin Zhou,Eileen M. Lafer	1992	42

About Shibin Zhou

Shibin Zhou is a scholar working on Biotechnology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 66 papers that have together received 14.9k indexed citations. Recurring topics across this work include Cancer Research and Treatments (19 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Virus-based gene therapy research (10 papers), CAR-T cell therapy research (10 papers), Nanoplatforms for cancer theranostics (9 papers), Bacteriophages and microbial interactions (7 papers), Lanthanide and Transition Metal Complexes (6 papers) and TGF-β signaling in diseases (6 papers). The work is most often cited by research in Cancer Research (3.8k citations), Biotechnology (1.6k citations) and Oncology (4.1k citations). Shibin Zhou has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Bert Vogelstein, Kenneth W. Kinzler, Luis A. Díaz, Nickolas Papadopoulos, Victor E. Velculescu, Jian Yu, Tong‐Chuan He, Luís Teixeira da Costa, Leigh Zawel and David Bermudes. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact